首页>
外国专利>
MIGRATION INHIBITORY FACTOR IN SERUM AS A TUMOR MARKER FOR PROSTATE, BLADDER, BREAST, OVARIAN, KIDNEY AND LUNG CANCER
MIGRATION INHIBITORY FACTOR IN SERUM AS A TUMOR MARKER FOR PROSTATE, BLADDER, BREAST, OVARIAN, KIDNEY AND LUNG CANCER
展开▼
机译:血清中作为前列腺癌,膀胱癌,乳腺癌,卵巢癌,肾癌和肺癌的肿瘤标志物的迁移抑制因子
展开▼
页面导航
摘要
著录项
相似文献
摘要
Macrophage migration inhibitory factor (MIF) has been found to be overexpressed in blood of individuals having various cancers, including prostate, PIN, lung, breast, ovary, kidney and bladder. Normal levels of MIF in serum of males and females without these cancers have been quantified via immunoassay. MIF can be used as a diagnostic tool either by itself or as an adjunct to or in combination with to conventional diagnostic tests.
展开▼